Zelda was found filthy, hungry and matted. Barely recognizable as a dog, her rescuers cleaned her up to reveal a tiny Shih Tzu. Unfortunately, Zelda’s story is similar to the nearly 8 million other animals entering shelters each year. That’s why Wahl has teamed up with GreaterGood.org to donate funds and grooming supplies to shelters nationwide. The goal: Transform more than 20,000 dogs this year and get them ready for adoption.
“Due to lack of resources, less than half of dogs entering shelters are getting the grooming they desperately need,” says Shay Moeller, pet product manager for Wahl. “First impressions are crucial, and without proper grooming, many of these dogs are perceived to be ‘damaged goods.’ By providing shelters with much-needed grooming supplies, we can transform these dogs into the healthy, fun loving pets they really are.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7828751-wahl-dirty-dogs-contest/
For the first time a YSL skincare product joins the collection at a science museum. Glycobiology, the science of glycans applied to the skin and cosmetics pioneered by YSL Beauté with FOREVER YOUTH LIBERATOR SERUM, is now part of the Berlin Museum‘s newly inaugurated permanent exhibition dedicated to the central role played by glycans in the realm of life.
After being closed for renovations for three years, the Berlin-based Sugar Museum has reopened as part of the Deutsches Technikmuseum with an expanded exhibition about sugars: “Sugars and Beyond! Food – Matter – Energy”, from November 26, 2015. In addition to the traditional focus of the former Sugar Museum, which concentrated on the production, use and social history of cane and beet sugars, the newly opened exhibition sheds light on the topic of sugar from entirely new perspectives.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7709551-ysl-beaute-forever-youth-liberator-serum/
The Prostate Cancer Foundation (PCF) and Major League Baseball (MLB) are once again teaming up to hit home runs for prostate cancer research and encourage fans to “Keep Dad in the Game” as part of the yearly celebration of Father’s Day and annual Home Run Challenge.
This year Joe Torre, MLB’s Chief Baseball Officer, Hall of Famer and prostate cancer survivor, encourages baseball fans everywhere to support PCF’s efforts to end prostate cancer by delivering an important public service announcement, “to step up to the plate, help save lives and get one step closer to finding a cure.”
“Joe has been a great partner in our progress toward improved treatment outcomes and an eventual cure,” said PCF Founder and Chairman Mike Milken. “His work as well as those by MLB and all 30 Clubs has helped us raise more than $45 million for research programs that are saving thousands of lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7729251-pcf-and-mlb-prostate-home-run-challenge/
Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
Nautilus Inc. (NYSE: NLS), a leader in innovative home fitness equipment, today announced the availability of the new Bowflex MAX Trainer™. Designed to take the popular elliptical experience to a new level, the MAX Trainer combines the movement of a traditional elliptical with a stair stepper to create a one-of-a-kind cardio workout.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64969-nautilus-inc-new-high-performance-cardio-machine-bowflex-max-trainer
Today, GENYOUth announced the launch of Fuel Up to Play 60 en español, an evolution of its national flagship program. The program encourages Spanish-speaking communities nationwide to live healthier lifestyles through good nutrition and physical activity. Fuel Up to Play 60 launched a redesigned website (FuelUpToPlay60.com) that provides Spanish-language content and materials, extending the reach and access of the program to students, teachers and families across the country. Several organizations have supported the effort, including the PepsiCo Foundation, which has provided a previously announced grant of $550,000 to develop Spanish-language materials and resources. In addition the PepsiCo Foundation will provide another $100,000 for mini-grants for health and wellness activities and programming within Los Angeles Unified School District and Miami-Dade County Public Schools.
Fuel Up to Play 60, a program founded by the National Football League (NFL) and National Dairy Council (NDC), is designed to engage and empower youth to take action for their own health by implementing long-term, positive nutrition and physical activity changes for themselves, their schools and their communities. Studies show that physical fitness may benefit brain health and academic performance, suggesting active kids may do better. However, only 1 in 3 kids are active every day, potentially leaving many at a disadvantage inside and outside of the classroom.
To view the multimedia release go to:
http://www.multivu.com/players/English/7646551-fuel-up-to-play-60/
Time for lunch!
Master chef and National Geographic Explorer Barton Seaver gives kid-friendly tips on how to pack an awesome healthy lunch from his new book, filled with scrumptious seasonal recipes, fun food facts and challenges, tips on sustainability, and more. Find out more at NGKidsCookbook.com Find other Cookbook segments at YouTube.com/natgeofan. Cooking, health, kids, non-fiction. self help
FDA’s Read the Label Youth Outreach Campaign is an exciting initiative that challenges kids (ages 9 to 13) to “get their food facts first” by using the Nutrition Facts Label to make healthy food choices. Read the Label campaign materials enable parents and caregivers to help kids use this important tool.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7106352-fda-read-the-label-youth-outreach-campaign-tweens-healthy-choices
For the first time ever in the UK, a gluten-free breakfast cereal will sit alongside other well-known brands in the mainstream cereal aisle, marking a breakthrough in the availability of gluten-free cereal products.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/72762533-nestle-gluten-free-cereal-launch/
Following years of trying to expand their family, Lisa and James Park of Raleigh, NC were named the winning family in Ferring Pharmaceuticals’ 2014 Heart to Heart Video Contest. This marks the tenth year Ferring has provided educational grants through patient contests, giving parents who have struggled with infertility the chance to win thousands of dollars for their child’s education by sharing their story.
Lisa and James’ rollercoaster journey to parenthood included multiple rounds of in vitro fertilization (IVF), intrauterine insemination (IUI) and a frozen embryo transfer. They hope that by sharing their story and video, they can help raise awareness about infertility and provide hope for others facing similar struggles. You can view Park family’s full video at www.hearttoheartcontest.com.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7444651-ferring-pharmaceuticals-heart-to-heart/
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today congratulated trusted Edwards partner Dr. Albert Starr on receiving the 2015 Institut de France’s Grand Prix Scientifique in a Paris awards ceremony.
The Grand Prix is one of the largest prizes for scientific accomplishment and is considered the world’s most prestigious prize for cardiovascular research. The Institut’s board awarded Starr the Grand Prix in recognition of research that led to the world’s first successful artificial mitral valve implant in 1960. In the last 55 years, millions of patients around the world have benefitted from the emergence of the field of heart valve replacement and the many technological advances that followed.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7536851-france-grand-prix-starr-edwards/
Abbott announced today that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States.
Absorb is the only fully dissolving stent approved for the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide, despite decades of therapeutic advances. While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in approximately three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants that restrict vessel motion for the life of the person treated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7826651-abbott-fda-approval-stent/
